A placebo-controlled trial of gabapentin in spinal muscular atrophy-Reference-Cited by-同舟云学术

A placebo-controlled trial of gabapentin in spinal muscular atrophy

Published:2001-10 Issue:1-2 Volume:191 Page:127-131
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Miller R.G.,Moore D.H.,Dronsky V.,Bradley W.,Barohn R.,Bryan W.,Prior T.W.,Gelinas D.F.,Iannaccone S.,Kissel J.,Leshner R.,Mendell J.,Mendoza M.,Russman B.,Samaha F.,Smith S.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference15 articles.

1. Spinal muscular atrophy;Iannaccone;Semin. Neurol.,1998

2. Identification and characterization of a spinal muscular atrophy-determining gene;Lefebvre;Cell,1995

3. The human centomeric survival of motor neuron gene (SMN2) rescues embryonic lethality in SMN mice and results in a mouse with spinal muscular atrophy;Monani;Hum. Mol. Genet.,2000

4. Reduced survival of motor neuron (SMN) gene dose in mice leads to motor neuron degradation: an animal model for spinal muscular atrophy type III;Jablonka;Hum. Mol. Genet.,2000

5. SMN oligomerization defects correlates with spinal muscular atrophy severity;Lorson;Nat. Genet.,1998

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges;Genes;2024-07-30

2. Psychometric evaluation of modified spinal muscular atrophy functional rating scale (SMAFRS) in adult patients using Rasch analysis;Muscle & Nerve;2023-01-15

3. Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy;Biology;2022-06-10

4. Biomarkers of disease progression in adolescents and adults with 5q spinal muscular atrophy: a systematic review and meta-analysis;Neuromuscular Disorders;2022-03

5. Clinical outcome assessments in Duchenne muscular dystrophy and spinal muscular atrophy: past, present and future;Neuromuscular Disorders;2021-10